Skip to main content

MoneyWorks4Me

Lupin informs about press release

08 Jun 2020 Evaluate

Lupin has informed that the Company enclosed a Press Release regarding grant of Orphan Drug Designation by US FDA to mexiletine hydrochloride for the treatment of myotonic disorders.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..